IFF
53
2
AVY
53
2
EQR
60
6
CTSH
65
-3
DFS
67
-3
MU
32
-6
AAPL
45
3
NSC
64
2
ADI
45
-5
MS
80
-3
PFG
50
-2
DVA
72
-3
EW
32
3
KSS
42
-3
BK
72
-2
SCHW
65
-2
BA
45
-3
EMR
77
-2
PX
73
-6
WMB
68
-2
IFF
53
2
AVY
53
2
EQR
60
6
CTSH
65
-3
DFS
67
-3
MU
32
-6
AAPL
45
3
NSC
64
2
ADI
45
-5
MS
80
-3
PFG
50
-2
DVA
72
-3
EW
32
3
KSS
42
-3
BK
72
-2
SCHW
65
-2
BA
45
-3
EMR
77
-2
PX
73
-6
WMB
68
-2
Financhill
Back

Inovio Pharmaceuticals Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
19

INO
Inovio Pharmaceuticals

Last Price:
4.81
Seasonality Move:
12.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Inovio Pharmaceuticals Price Quote

$4.81
-0.15 (-3.02%)
(Updated: November 14, 2024 at 5:55 PM ET)

Inovio Pharmaceuticals Key Stats

Sell
19
Inovio Pharmaceuticals (INO) is a Sell
Day range:
$4.94 - $5.26
52-week range:
$4.20 - $14.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.38%
Volume:
610.4K
Avg. volume:
312.1K
1-year change:
18.1%
Market cap:
$133.7M
Revenue:
$832K
EPS:
$-5.11

How Much Does Inovio Pharmaceuticals Make?

Data Unavailable

Is Inovio Pharmaceuticals Growing As A Company?

Inovio Pharmaceuticals Stock Price Performance

What Is Inovio Pharmaceuticals 52-Week High & Low?

Inovio Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Inovio Pharmaceuticals?

Is Inovio Pharmaceuticals Cash Flow Positive?

  • What Is INO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$112.4M
  • What Is Inovio Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $24.2M
  • What Is Inovio Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $69.8M

Inovio Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    INO return on invested capital is -91.32%
  • What Is Inovio Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -70.72%
  • What Is INO Return On Equity?
    ROE is a measure of profitability and is -98.72%

Inovio Pharmaceuticals Earnings Date & Stock Price

Inovio Pharmaceuticals Competitors

Inovio Pharmaceuticals Dividend Yield

Inovio Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -8.02%
Revenue: -55.41% -17.07%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 15.75
Upside from Last Price: 217.54%

Major Shareholders

  • How many INO shares are owned by institutional investors?
    12.7M INO shares are owned by institutional investors
  • How many INO shares are owned by insiders?
    4.6M INO shares are owned by insiders